Comparing Surgical With Percutaneous Revascularization in Three-vessel Disease: Current Status

Authors

  • Anastasios Salahas

DOI:

https://doi.org/10.2015/hc.v3i1%20sup.138

Keywords:

percutaneous coronary intervention, coronary artery bypass grafting, coronary artery disease, coronary stenting, coronary angioplasty

Abstract

Percutaneous coronary intervention (PCI) is an alternative therapeutic modality to coronary artery bypass surgery (CABG) for the revascularization of patients with multivessel coronary artery disease (CAD). Its effectiveness has been questioned because of higher rates of repeat revascularization and anginal attacks compared to CABG.Over the recent years drug eluting stents (DES) have been used for the management of patients with multivessel CAD as a major breakthrough technology in terms of a remarkable reduction of restenosis and repeat revascularization. Results from the Artery Revascularization Therapies (ARTS II) study indicate that DES and CABG have comparative effectiveness in major adverse cardiac events (MACE) in patients with multivessel CAD. Whether DES will replace CABG in the revascularization of patients with multivessel disease remains to be seen by the impending results of ongoing multicenter comparative trials.

Downloads

Issue

Section

Athens Cardiology Update 2008